Update, October 31, 2026
Broadcom (AVGO) fell 5.5% on Friday to $326.08, closing near its round support at $325.0, as the semiconductor sector lost roughly $1 trillion in market value after Intel's weak guidance triggered a broad selloff (Benzinga). Over five days, AVGO is still up 1.4%, while SOXX is down 1.4% and SPY is down 0.6%, so the stock continues to outperform its sector. The picture holds: the weekly downtrend remains intact, with price below its 40-week average and the 50-day SMA at $352.81 acting as resistance. The downside breakout level of a daily close below $325.0 is now being tested; a break would open the path toward the 52-week low at $293.41, though the reward-to-risk at that target is only 1.5, below the 3-to-1 threshold. The swing zone at $342.81 remains the key ceiling where sellers have appeared, and a weekly close above $352.81 would change the picture.
Friday's drop was part of a sector-wide move, not company-specific news, and the stock's relative strength versus SOXX over 50 days (+3.5%) persists. The 14-day RSI at 37.28 is approaching oversold, and historical data shows that after a one-day drop of more than 5%, AVGO has been higher a month later 70.9% of the time (median +5.4%). However, with the long-term trend down and the stock lagging SPY by 6.1% over 50 days, the bearish stance with medium conviction remains appropriate. The next earnings on December 9 could provide a catalyst, but until price action changes, the downside bias stays.
Broadcom (AVGO) trades at $347.60 after a $63 billion bank package for Anthropic's chip purchases helped lift the shares about 1.5% today. The weekly trend is still down, and the balance of evidence leans negative with medium conviction. The stock sits below its 40-week average and just under resistance at $350. The deal eases a financing worry without repairing the chart. A weekly close above $357.11 would change that.
Why it matters
On October 26, 2026, Bank of America, Citigroup, Morgan Stanley and Blackstone unveiled a $63 billion package to finance Anthropic's AI chip purchases. TheStreet reports that CEO Hock Tan spent nearly two months persuading banks to commit more than $40 billion, and agreed to higher interest rates after some lenders weighed walking away. The deal shows a large customer's orders now have funding behind them. It also shows that the funding came at a price, and that some lenders hesitated.
The market had priced in a lot of doubt. Broadcom closed Monday at $329.17, according to Morningstar, and has since bounced to $347.60. That still leaves it 7.7% below its October 7 close of $376.51. The bounce has taken the price back into the zone between $342.81 and $350, where buyers and sellers have both shown up before. Volume is far below its 20-day average, but the session is only minutes old, so that figure means little yet.
Most of the five-day gain came from the market and the sector, not from Broadcom. The stock is up 2.9% over five days, against a 0.2% decline for SPY and a 2.2% gain for SOXX, so it beat its sector by only 0.7 point. Chip shares were lifted this week as Barron's describes SK Hynix's strong earnings and rising physical shipments easing worries about AI demand. Today SOXX is up 3.9% against 1.5% for Broadcom, so the stock is lagging the rebound it is part of. Over one month SOXX is down 10.8% while Broadcom is down 0.6%. The news explains the direction of the move, but not why Broadcom has lagged on the way up.
The argument about AVGO is whether AI customers can pay for what they have ordered. The case for the stock is that D.A. Davidson's Gil Luria upgraded it to Buy and raised his price target to $400 from $350. He made the call contingent on AI startups including Anthropic delivering, and noted that Broadcom is roughly flat on the year while the PHLX Semiconductor Index has risen about 60%. The case against is that Anthropic's IPO filing shows commitments of more than $516.5 billion for hardware and cloud infrastructure. Morningstar flags the missing detail on valuation and price. Bloomberg reports that yields on AI-related debt are rising sharply, with several reaching double digits. Analysts remain strongly positive: 48 of them have a mean target of $530.14, and the stock trades 34.4% below it. The targets range from $215.88 to $660, so even the analysts disagree widely on what the shares are worth.
What the evidence says
The long-term thesis is weakened, not broken. The stock is below both its 10-week and 40-week averages, and below its 50-day average ($353.83) and 200-day average ($367.77). It is 27.8% under its 52-week high of $481.57 and 18.5% above its low of $293.41, and it is down 13.1% over six months. That is a corrective downtrend that has not yet found a floor. The demand story in the news is intact, but the price has stopped confirming it.
Over the next two to six weeks the balance of evidence leans negative, with medium conviction: two of four points. The daily trend runs with the weekly downtrend, which is the main point in favor. Broadcom also trails the S&P 500 by 2.2% over 50 days, and by 10.8% over 200 days. The strongest case against this reading is relative strength within chips. Broadcom leads SOXX by 1.1% over 50 days, and a stock that holds up better than its sector during a sector pullback can lead the recovery. The RSI at 43.1 is also not oversold, so the stock has room to fall further, but that cuts both ways. That leading position against the sector is why conviction is not higher. It does not tip the balance because the stock still sits below every major average and below $350, where sellers have appeared on rallies.
Levels that matter
The structure holds below $350, a round number where sellers have shown up on rallies, with the 50-day average at $353.83 just above it. The weekly trend would end above $357.11, a swing zone, on a weekly close. Between those two levels the downtrend is intact, and the next resistance after that is the 200-day average at $367.77.
The breakout level is a daily close below $342.81, a swing-zone support. From there the target is the 52-week low at $293.41, with $325 and $300 as stops along the way. A break would be wrong above $352.79, which is $350 plus a quarter of the 14-day ATR of $11.14. That gives 4.9 to 1 reward to risk, which clears the 3 to 1 that makes a breakout worth the risk.
What would change the picture
The rule is a weekly close above $357.11. That would put the price above the zone where the downtrend has been defended and would be the first sign that buyers are back. The non-price fact that could do it is confirmation that the Anthropic financing is funded and turning into chip orders, while the debt market keeps absorbing AI paper without yields climbing further.
What to watch
- Earnings: December 9, 2026. The number that matters is AI-related revenue and the guidance for it, because that is what the financing is meant to support.
- Sector events before then: the Federal Reserve's 2pm ET decision today, expected to be a hawkish hold according to CNBC; big-tech earnings later this week; and the AI debt market, where rising yields would test the financing story.
- Valuation: at $347.60 the stock trades 34.4% below the $530.14 mean target, and the $215.88 to $660 spread shows how little consensus there is on what AI demand is worth.